Industry Roundup: NBTY China JV, Bucks For Bugs
This article was originally published in The Tan Sheet
Executive Summary
Nellson consolidates in Anaheim; Plant Based Food group opens; Bots builds BioPharmx business; and more news in brief.
You may also be interested in...
Nature's Bounty Returns To Top Billing As NBTY's New Name
The firm owned since 2010 by a Carlyle Group holding company opts for a name that encompasses its largest brand, which also had been its name until the previous management chose the name NBTY in 1995.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.